Atara shares have exploded to gain over 100% in the last five days after the Thousand Oaks-based biotech finally received good news from the U.S. Federal Drug Administration. On May 7, Atara announced that it had a “productive meeting” with the FDA to find a potential path forward to resubmitting the tab-cel Biologics License Application.…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
